"10.1371_journal.pone.0104165","plos one","2014-08-05T00:00:00Z","Philip Brenner; Kristina Alexanderson; Charlotte Björkenstam; Jan Hillert; Jussi Jokinen; Ellenor Mittendorfer-Rutz; Petter Tinghög","Division of Psychiatry, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Division of Neuro, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden","Conceived and designed the experiments: PB KA JJ PT. Performed the experiments: PB PT. Analyzed the data: PB KA CB JH JJ EMR PT. Contributed to the writing of the manuscript: PB KA CB JH JJ EMR PT.","Biogen Idec provided funding toward this study. JH has over the years received honoraria for serving on advisory boards for BiogenIdec and Novartis and speaker's fees from BiogenIdec, Merck-Serono, Bayer-Schering, Teva and Sanofi-Aventis. He has served as P.I. for projects, or received unrestricted research support from, BiogenIdec, Merck-Serono, TEVA, Sanofi-Aventis and Bayer-Schering and is in the process of negotiating a research grant from Novartis. There are no patents, products in development or marketed products to declare. This does not alter adherence to all the PLOS ONE policies on sharing data and materials.","2014","08","Philip Brenner","PB",7,TRUE,4,2,7,NA,TRUE,TRUE,FALSE,0,NA,FALSE
